Moderna, Inc. (MRNA)
Moderna's stock climbs on report that bird-flu vaccine funding is near
Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.
Option Trade On Volatile Moderna Could Return 28% By Mid-July
This iron condor trade on Moderna has the potential to return 28% if the stock price stays between 118.90 and 181.10.
U.S. Government Nears Deal To Fund Moderna mRNA Bird Flu Shot Trial, Report Says
The U.S. government is closing in on a deal to fund a late-stage trial for an mRNA pandemic bird flu vaccine made by Moderna, the Financial Times reported Thursday, at a time when the country is battling an H5N1 outbreak in cattle and poultry farms.
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
The U.S. government is nearing an agreement to fund a late-stage trial of Moderna's mRNA pandemic bird flu vaccine, the Financial Times reported on Thursday, as an H5N1 outbreak spreads through egg farms and among cattle herds.
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
Biotech stocks are not for the faint of heart. It is a sector that can provide life-changing gains or cause an investment to head towards zero.
Moderna Shares Had a Bad Day. Here's Why.
The drop comes as Moderna awaits important developments involving its experimental cancer treatment, a new respiratory vaccine, and a possible avian flu vaccine under development.
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Shares of Moderna (MRNA) are being driven by encouraging pipeline updates and plans for potential product launches.
Should You Buy This Stock After a Regulatory Setback?
Moderna's leading non-COVID candidate won't earn approval when the biotech hoped. However, the delay should be a relatively short one if we believe the word of regulators.
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu vaccines over increasing fears of widespread transmission of the infection.
The Moderna News That Has MRNA Stock Price Surging This Week: 3 Key Catalysts
Moderna (NASDAQ: MRNA ) stock is up more than 20% in just the past five trading sessions as investors foresee strong growth opportunities for the biotechnology firm. Indeed, the company has climbed 44% so far this year as one of the big winners of 2024's bull market.
The Moderna News That Has MRNA Stock Price Surging: 3 Key Catalysts
Moderna (NASDAQ: MRNA ) stock is up more than 20% in just the past five trading sessions as investors foresee strong growth opportunities for the biotechnology firm. Indeed, the company has climbed 44% so far this year as one of the big winners of 2024's bull market.
Moderna Has Big AI News. Is the Stock a Buy?
Moderna has been using artificial intelligence (AI) for years to save precious time in the laboratory. But the biotech isn't stopping there.
